Related references
Note: Only part of the references are listed.Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
Chun-Jen Liu et al.
HEPATOLOGY INTERNATIONAL (2013)
Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B
Young Eun Chon et al.
ANTIVIRAL THERAPY (2011)
Risk of HBV reactivation according to viral status and treatment intensity in patients with hepatocellular carcinoma
Jeong Won Jang et al.
ANTIVIRAL THERAPY (2011)
Clinical and Virological Responses to Clevudine Therapy of Hepatocelluar Carcinoma Patients with Chronic Hepatitis B
Sang Myung Woo et al.
GUT AND LIVER (2011)
Quantitative Hepatitis B Surface Antigen and Hepatitis B e Antigen Titers in Prediction of Treatment Response to Entecavir
Jung Min Lee et al.
HEPATOLOGY (2011)
Treatment of chronic hepatitis B: Evolution over two decades
Man-Fung Yuen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Hepatitis B virus resistance to antiviral drugs: where are we going?
Fabien Zoulim
LIVER INTERNATIONAL (2011)
Chronic Hepatitis B and Hepatocellular Carcinoma
Amy C. McClune et al.
CLINICS IN LIVER DISEASE (2010)
Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: A review of 16 patients
Masaaki Watanabe et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2010)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Usefulness of FibroScan for Detection of Early Compensated Liver Cirrhosis in Chronic Hepatitis B
Do Young Kim et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial
Lorenza Rimassa et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Antiviral Resistance and Hepatitis B Therapy
Marc G. Ghany et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Nucleotide Analogs for Patients with HBV-Related Hepatocellular Carcinoma Increase the Survival Rate through Improved Liver Function
Masahiko Koda et al.
INTERNAL MEDICINE (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma
Ji Hoon Kim et al.
LIVER INTERNATIONAL (2009)
Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis
Kwang-Hyub Han et al.
CANCER (2008)
Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors
Seung Up Kim et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Hepatitis B: Reflections on the current approach to antiviral therapy
Fabien Zoulim et al.
JOURNAL OF HEPATOLOGY (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma
Ji Hoon Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma
Jun Yong Park et al.
CANCER (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization
JW Jang et al.
HEPATOLOGY (2006)
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
MW Yu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B
CL Lai et al.
CLINICAL INFECTIOUS DISEASES (2003)
Interventional radiology for advanced hepatocellular carcinoma: Comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization
S Sumie et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2003)
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
ASF Lok et al.
GASTROENTEROLOGY (2003)
Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis
S Ueno et al.
HEPATOLOGY RESEARCH (2002)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Share Paper
